Applications for the 2026-2027 class have closed. Human genetics and genomics are advancing at an extraordinary pace, and the field needs informed, compelling voices who can help policymakers understand and support our work. The ACGT Program was created to empower emerging scientists with the tools to contribute to the conversation, equipping them with the policy... Read More
While summer in Washington D.C. is usually a quiet time – both the U.S. Senate and the House of Representatives traditionally break for a recess for most of the month of August – this year is looking to be the exception. Congress is having a busier summer than usual as legislation for politically charged issues... Read More
ASHG supports policies that promote genetic and genomic data sharing to advance research and health care with strong protections in place for genetic information. The Society is concerned that a provision in the Senate-passed U.S. Innovation and Competition Act (USICA, S.1260), that requires NIH to consider national security risks in the conduct of human genomic... Read More
A draft bill introduced in May 2019 sought to reform Section 101 of the U.S. Patent Act. If passed, the legislation would allow for the patenting of genes by effectively overturning the 2013 Association for Molecular Pathology (AMP) vs. Myriad Supreme Court decision. Related: Joint Letter from ASHG and ACMG Leadership to Bill Sponsors (July... Read More